207 related articles for article (PubMed ID: 26281123)
1. Trends of Immunosuppression and Outcomes Following Liver Transplantation: An Analysis of the United Network for Organ Sharing Registry.
Cheng EY; Everly MJ
Clin Transpl; 2014; ():13-26. PubMed ID: 26281123
[TBL] [Abstract][Full Text] [Related]
2. Pancreas transplant outcomes for United States (US) cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR).
Gruessner AC; Sutherland DE
Clin Transpl; 2008; ():45-56. PubMed ID: 19708445
[TBL] [Abstract][Full Text] [Related]
3. Liver transplant: a primer.
Movahedi Z; Holt CD; Saab S
Exp Clin Transplant; 2010 Jun; 8(2):83-90. PubMed ID: 20565363
[TBL] [Abstract][Full Text] [Related]
4. Organ Procurement and Transplantation Network/Scientific Registry of Transplant Recipients 2014 Data Report: Intestine.
Cai J; Wu G; Qing A; Everly M; Cheng E; Terasaki P
Clin Transpl; 2014; ():33-47. PubMed ID: 26281125
[TBL] [Abstract][Full Text] [Related]
5. Impact of sirolimus and tacrolimus on mortality and graft loss in liver transplant recipients with or without hepatitis C virus: an analysis of the Scientific Registry of Transplant Recipients Database.
Watt KD; Dierkhising R; Heimbach JK; Charlton MR
Liver Transpl; 2012 Sep; 18(9):1029-36. PubMed ID: 22641474
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-2 receptor antibody does not reduce rejection risk in low immunological risk or tacrolimus-treated intermediate immunological risk renal transplant recipients.
Lim WH; Chadban SJ; Campbell S; Dent H; Russ GR; McDonald SP
Nephrology (Carlton); 2010 Apr; 15(3):368-76. PubMed ID: 20470309
[TBL] [Abstract][Full Text] [Related]
7. An Update on Cardiac Transplantation in the United States.
Everly MJ
Clin Transpl; 2014; ():27-32. PubMed ID: 26281124
[TBL] [Abstract][Full Text] [Related]
8. The impact of early corticosteroid withdrawal on graft survival in liver transplant recipients.
Meadows HB; Taber DJ; Pilch NA; Tischer SM; Baliga PK; Chavin KD
Transplant Proc; 2012 Jun; 44(5):1323-8. PubMed ID: 22664009
[TBL] [Abstract][Full Text] [Related]
9. Calcineurin inhibitors in liver transplantation: to be or not to be.
Castroagudín JF; Molina E; Varo E
Transplant Proc; 2011; 43(6):2220-3. PubMed ID: 21839238
[TBL] [Abstract][Full Text] [Related]
10. Intestinal Transplantation: International Outcomes.
Ganoza AJ; Farmer DG; Marquez MA; Mazariegos GV
Clin Transpl; 2014; ():49-54. PubMed ID: 26281126
[TBL] [Abstract][Full Text] [Related]
11. Primary immunosuppression and outcome differences after heart transplantation: tacrolimus versus cyclosporine.
Castel MA; Farrero M; Vallejos I; Cardona M; Regueiro A; Pérez-Villa F
Transplant Proc; 2011; 43(6):2244-6. PubMed ID: 21839245
[TBL] [Abstract][Full Text] [Related]
12. Cold ischemia is a major determinant of acute rejection and renal graft survival in the modern era of immunosuppression.
Mikhalski D; Wissing KM; Ghisdal L; Broeders N; Touly M; Hoang AD; Loi P; Mboti F; Donckier V; Vereerstraeten P; Abramowicz D
Transplantation; 2008 Apr; 85(7 Suppl):S3-9. PubMed ID: 18401260
[TBL] [Abstract][Full Text] [Related]
13. Trends in renal transplantation in patients with human immunodeficiency virus infection: an analysis of the United States renal data system.
Yoon SC; Hurst FP; Jindal RM; George SA; Neff RT; Agodoa LY; Kimmel PL; Abbott KC
Transplantation; 2011 Apr; 91(8):864-8. PubMed ID: 21301399
[TBL] [Abstract][Full Text] [Related]
14. The UNOS Renal Transplant Registry: Review of the Last Decade.
Andre M; Huang E; Everly M; Bunnapradist S
Clin Transpl; 2014; ():1-12. PubMed ID: 26281122
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppressive regimens and their effects on renal allograft outcome.
Katznelson S; Cecka JM
Clin Transpl; 1996; ():361-71. PubMed ID: 9286582
[TBL] [Abstract][Full Text] [Related]
16. Impact of Induction Immunosuppression Strategies in Simultaneous Liver/Kidney Transplantation.
Kamal L; Yu JW; Reichman TW; Kang L; Bandyopadhyay D; Kumar D; King A; Gautam U; Bhati C; Yakubu I; Lacy K; Levy M; Gupta G
Transplantation; 2020 Feb; 104(2):395-403. PubMed ID: 31022149
[TBL] [Abstract][Full Text] [Related]
17. Present state of immunosuppressive therapy in liver transplant recipients.
Wiesner RH; Fung JJ
Liver Transpl; 2011 Nov; 17 Suppl 3():S1-9. PubMed ID: 21850697
[TBL] [Abstract][Full Text] [Related]
18. Is there such a thing as protocol immunosuppression in liver transplantation?
McCaughan GW; Sze KC; Strasser SI
Expert Rev Gastroenterol Hepatol; 2015 Jan; 9(1):1-4. PubMed ID: 25164689
[TBL] [Abstract][Full Text] [Related]
19. Safety of blood group A2-to-O liver transplantation: an analysis of the United Network of Organ Sharing database.
Kluger MD; Guarrera JV; Olsen SK; Brown RS; Emond JC; Cherqui D
Transplantation; 2012 Sep; 94(5):526-31. PubMed ID: 22874840
[TBL] [Abstract][Full Text] [Related]
20. Living-donor liver transplantation at the University of Tokyo, 1996-2011: the impact of HLA matching and a positive crossmatch on long-term survival and tolerance.
Waki K; Sugawara Y; Mizuta K; Fujita H; Kadowaki T; Kokudo N
Clin Transpl; 2011; ():223-35. PubMed ID: 22755416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
